Ken Smith, Director, risk management, Regeneron Pharmaceuticals, Inc
Ken Smith is the director of risk management at Regeneron Pharmaceuticals, a science and technology company based in Tarrytown, New York, which has developed six FDA-approved medicines and numerous product candidates for a range of conditions, including asthma, pain, cancer and infectious diseases.
An industry peer describes Smith as “a valuable resource to his company across the board. His skill set is far-reaching, and his knowledge vast. He is able to compartmentalize each risk and apply a solid fundamental approach to each subject. He uses that as his basis in constructing a solid risk management plan.”